Martin Christopher Nathan bought EWTX
June 5, 2026 · Form 4 insider transaction
Martin Christopher Nathan bought 16,377 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,377
Price
$0.00
Total value
N/A
InsiderMartin Christopher Nathan
RoleDirector
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 16, 2026
Shares owned after16,377
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.